International Gemmological Institute (India) Ltd

- As of the earnings call dated January 27, 2026, there was no mention of any ongoing or planned fundraising through debt or equity. - The company currently holds around INR 860 crores in cash across the group. - The management indicated a capital allocation strategy combining dividends and maintaining cash reserves for potential mergers and acquisitions (M&A). - The company is evaluating M&A options but has not disclosed any specific plans for new fundraising. - Overall, there is a focus on using operating cash flow either for dividends or acquisitions rather than raising new capital through debt or equity at this time.

- IGI is continuously evaluating M&A (merger and acquisition) options as part of its capital allocation strategy. - Future capital allocation will be a combination of dividends to shareholders and potential acquisitions. - The company is reinvesting resources into building organizational capability and strength, particularly in the US market, including building a strong sales organization. - There is ongoing focus on capacity building through mass hiring, especially of graders, to support volume growth and improve turnaround times. - No specific details or amounts on capex were disclosed; emphasis is on strategic investments via acquisitions and talent capacity expansion.

- IGI expects continued robust growth in lab-grown diamond segment, supported by significant capacity additions by manufacturers and emerging lab-grown jewellery trend in India. - Volume growth target is around 15%-20% annually, maintaining earlier strong growth momentum despite seasonal fluctuations. - Revenue growth driven by both volume and stable average selling price (ASP), with no expected significant structural changes in pricing for lab-grown diamonds (ASP ~ ₹900-950). - Natural diamond certifications are also growing strongly (45% growth in Q4 '25), driven by increased certification to assure origin amid rising lab-grown awareness. - Lab-grown diamond certification volume expected to double in next three years due to capacity expansions and retail penetration. - IGI aims to sustain and improve market share in natural diamonds alongside lab-grown segments, emphasizing customer experience and turnaround times. - Management is confident of repeating or exceeding the strong 2025 performance given persistent industry tailwinds.

- The company expects to repeat its strong performance from 2025 into 2026, supported by robust industry tailwinds. - Growth drivers include expansion in lab-grown diamond capacity and emerging lab-grown jewelry retail chains, especially in India. - Management is confident of sustaining volume growth close to the 15%-20% range based on past performance and market dynamics. - EBITDA and PAT are expected to maintain upward momentum, bolstered by operating leverage and cost rationalization efforts, particularly in international operations. - Price stability in lab-grown diamonds is anticipated, with a focus on maintaining market stability rather than dramatic price increases. - Capital allocation will balance dividends with strategic investments, including potential mergers and acquisitions to fuel growth. - Overall, strong revenue, margin expansion, and cash flow generation are targeted, with an emphasis on technology, capacity building, and market penetration.

The transcript in the provided pages does not explicitly mention the current or expected order book or pending orders for International Gemmological Institute (IGI) India Limited. However, relevant insights include: - Volume and revenue growth indicate strong demand and order flow: 21% year-on-year volume growth (12.81 million reports in 2025 vs. 10.57 million in 2024). - Continued mass hiring to support scaling volumes suggests a healthy pipeline. - The company is experiencing exponential growth in certification volumes, especially for natural diamonds (ND) and lab-grown diamonds (LGD). - Efforts to optimize turnaround times and customer experience indicate sustained order intake. - Growth driven by robust tailwinds in lab-grown and natural diamond markets supports continued order flow. - Strategic evaluation of M&A options and steady dividend payouts show confidence in business prospects. No specific numeric order book or pending order data is provided.